Project TitleImproved Nanoparticle Based Targeted Drug Delivery to Cancerous Cells and Tissues
Track Code2017-YEO-67767
Short Description

Yoon Yeo

Yeo Lab

Purdue Industrial and Physical Pharmacy

Tagscancer, cancer therapy, drug delivery, Medical/Health, nanoparticles, pharmaceuticals
Posted DateOct 10, 2017 2:53 PM


Yoon Yeo
Jun Xu

Improved Nanoparticle Based Targeted Drug Delivery to Cancerous Cells and Tissues


Cancer is a group diseases involving abnormal cell growth. Currently there are more than 100 types of identified cancer that affect human beings as well as animals. In 2016, there were an estimated 1,685,210 new human cancer cases diagnosed and 595,690 cancer deaths in the United States alone (Cancer Statistics 2016 - American Cancer Society, Inc.). Nanoparticles (NPs) have been considered a promising carrier of chemotherapeutic drugs, but are limited in delivery to tumors due to the diverse nature of the disease. There currently exists the need to leverage the enhanced permeability and retention effect to deliver NPs beyond the current levels possible.

Technology Summary

Researchers at Purdue University have developed a method for preparing polyol-modified nanoparticles for targeted delivery to cancerous cells and tissues via transcytosis across the peritumoral endothelium. This method does not depend on the leakiness of the vasculature like traditional nanoparticle formulations, but actively interacts with the vascular lining to enter tumors.


  • Increases the amount of drugs deliver to solid tumors
  • Reduces the required dose and related side effects
  • Does not depend on long-term circulation and passive extravasation

Potential Applications

  • Cancer treatment
  • Drug delivery

Stage of Development

Preclinical testing performed

Web Links

For additional information, please contact

Intellectual Property

Patent Number Issue Date Type Country of Filing
None None Provisional United States